|
1
|
Jiang H, Duan B, He C, et al: Cytoplasmic
HSP90α expression is associated with perineural invasion in
pancreatic cancer. Int J Clin Exp Pathol. 7:3305–3311. 2014.
|
|
2
|
Spano JP, Chodkiewicz C, Maurel J, et al:
Efficacy of gemcitabine plus axitinib compared with gemcitabine
alone in patients with advanced pancreatic cancer: An open-label
randomised phase II study. Lancet. 371:2101–2108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
López R, Méndez CM, Fernández MJ, et al:
Phase II trial of erlotinib plus capecitabine as first-line
treatment for metastatic pancreatic cancer (XELTA study).
Anticancer Res. 33:717–723. 2013.PubMed/NCBI
|
|
4
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chung TW, Choi HJ, Kim SJ, et al: The
ganglioside GM3 is associated with cisplatin-induced apoptosis in
human colon cancer cells. PLoS One. 9:e927862014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gresham GK, Wells GA, Gill S, Cameron C
and Jonker DJ: Chemotherapy regimens for advanced pancreatic
cancer: A systematic review and network meta-analysis. BMC Cancer.
14:4712014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramfidis VS, Psyrri A, Syrigos KN and Saif
MW: First line treatment for metastatic pancreatic adenocarcinoma:
Looking for the step forward. JOP. 15:286–288. 2014.PubMed/NCBI
|
|
8
|
Entz-Werlé N, Choquet P, Neuville A, et
al: Targeted apc;twist double-mutant mice: A new model of
spontaneous osteosarcoma that mimics the human disease. Transl
Oncol. 3:344–353. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohuchida K, Mizumoto K, Ohhashi S, et al:
Twist, a novel oncogene, is upregulated in pancreatic cancer:
Clinical implication of Twist expression in pancreatic juice. Int J
Cancer. 120:1634–1640. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Breit SN, Johnen H, Cook AD, et al: The
TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine
with roles in inflammation, cancer and metabolism. Growth Factors.
29:187–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mimeault M and Batra SK: Divergent
molecular mechanisms underlying the pleiotropic functions of
macrophage inhibitory cytokine-1 in cancer. J Cell Physiol.
224:626–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khaled YS, Elkord E and Ammori BJ:
Macrophage inhibitory cytokine-1: A review of its pleiotropic
actions in cancer. Cancer Biomark. 11:183–190. 2012.PubMed/NCBI
|
|
13
|
Koopmann J, Buckhaults P, Brown DA, et al:
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic
and other periampullary cancers. Clin Cancer Res. 10:2386–2392.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ozkan H, Demirbaş S, Ibiş M, Akbal E and
Köklü S: Diagnostic validity of serum macrophage inhibitor cytokine
and tissue polypeptide-specific antigen in pancreatobiliary
diseases. Pancreatology. 11:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen YZ, Liu D, Zhao YX, Wang HT, Gao Y
and Chen Y: Diagnostic performance of serum macrophage inhibitory
cytokine-1 in pancreatic cancer: A meta-analysis and
meta-regression analysis. DNA Cell Biol. 33:370–377. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsuo N, Shiraha H, Fujik T, et al: Twist
expression promotes migration and invasion in hepatocellular
carcinoma. BMC Cancer. 9:2402009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang B, Feng P, Xiao Z and Ren EC: LIM and
SH3 protein 1 (Lasp1) is a novel p53 transcriptional target
involved in hepatocellular carcinoma. J Hepatol. 50:528–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng Y, Hu J, Ma J, et al: RNAi-mediated
silencing of VEGF-C inhibits non-small cell lung cancer progression
by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and
VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling
pathways. Eur J Cancer. 47:2353–2363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jo YK, Park SJ, Shin JH, et al: ARP101, a
selective MMP-2 inhibitor, induces autophagy-associated cell death
in cancer cells. Biochem Biophys Res Commun. 404:1039–1043. 2011.
View Article : Google Scholar
|
|
20
|
Qazi H, Shi ZD and Tarbell JM: Fluid shear
stress regulates the invasive potential of glioma cells via
modulation of migratory activity and matrix metalloproteinase
expression. PLoS One. 6:e203482011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding X, Zhang Z, Li S and Wang A:
Combretastatin A4 phosphate induces programmed cell death in
vascular endothelial cells. Oncol Res. 19:303–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Wu H and Miller AH: Interleukin
1alpha (IL-1alpha) induced activation of p38 mitogen-activated
protein kinase inhibits glucocorticoid receptor function. Mol
Psychiatry. 9:65–75. 2004. View Article : Google Scholar
|
|
23
|
Leelahavanichkul K, Amornphimoltham P,
Molinolo AA, Basile JR, Koontongkaew S and Gutkind JS: A role for
p38 MAPK in head and neck cancer cell growth and tumor-induced
angiogenesis and lymphangiogenesis. Mol Oncol. 8:105–118. 2014.
View Article : Google Scholar :
|
|
24
|
Li Y, Liao Q, Li K, Zhong D, Weng X and Mi
M: Knockdown of endothelin A receptor expression inhibits
osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse
model. Mol Med Rep. 5:1391–1395. 2012.PubMed/NCBI
|
|
25
|
Cui XP, Qin CK, Zhang ZH, et al: HOXA10
promotes cell invasion and MMP-3 expression via TGFβ2-mediated
activation of the p38 MAPK pathway in pancreatic cancer cells. Dig
Dis Sci. 59:1442–1451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan F, Ma S, Cao W, et al: SDF-1α
upregulation of MMP-2 is mediated by p38 MAPK signaling in
pancreatic cancer cell lines. Mol Biol Rep. 40:4139–4146. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Liao Q, He H, Zhong D and Yin K:
TWIST interacts with β-catenin signaling on osteosarcoma cell
survival against cisplatin. Mol Carcinog. 53:440–446. 2014.
View Article : Google Scholar
|
|
28
|
Bauskin AR, Brown DA, Kuffner T, et al:
Role of macrophage inhibitory cytokine-1 in tumorigenesis and
diagnosis of cancer. Cancer Res. 66:4983–4986. 2006. View Article : Google Scholar : PubMed/NCBI
|
